Business

Weight-loss drug battle: Who are the latest players involved (MRK:NYSE)

Mar. 08, 2025 1:30 PM ETMerck & Co., Inc. (MRK) Stock, LLY Stock, NVS Stock, NVO Stock, AZN Stock, ALT Stock, PFE Stock, ABBV Stock, AMGN Stock, REGN Stock, VKTX Stock, ARWR Stock, VERU Stock, RSLS Stock, RYTM Stock, GPCR Stock, BHVN Stock, SRRK Stock, TERN Stock, KROS Stock, VTYX Stock, ALUR Stock, BIOA Stock, MTSR Stock, RHHBY Stock, ZLDPF Stock, HNSPF StockBy: Tiyashi Datta, SA News Editor
Weight-loss drug battle: Who are the latest players involved (MRK:NYSE)

choi dongsu

The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) diving into the opportunity to make effective and targeted anti-obesity products to fulfil the unprecedented demand.

The increase


Source link

Related Articles

Back to top button